Reply to 'Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality'.

Dauby, N; Catteau, L; Hautekiet, J; Montourcy, M; Bottieau, E; Goetghebeur, E; Van Beckhoven, D

Dauby, N; Catteau, L; Hautekiet, J; Montourcy, M; Bottieau, E; Goetghebeur, E; Van Beckhoven, D.

Afiliação

Dauby N; Department of Infectious Diseases, CHU Saint-Pierre, Brussels, Belgium; Institute for Medical Immunology, Université Libre de Bruxelles (ULB), Brussels, Belgium; Environmental Health Research Centre, Public Health School, Université Libre de Bruxelles (ULB), Brussels, Belgium. Electronic address: Ni
Catteau L; Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Hautekiet J; Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium; Cancer Centre, Sciensano, Brussels, Belgium.
Montourcy M; Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Bottieau E; Department of Clinical Sciences, Institute for Tropical Medicine, Antwerp, Belgium.
Goetghebeur E; Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium.
Van Beckhoven D; Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Int J Antimicrob Agents ; 57(2): 106261, 2021 02.

Article em En | MEDLINE | ID: mdl-33321211

Assuntos

Tratamento Farmacológico da COVID-19; Infecções por Coronavirus; Azitromicina; Humanos; Hidroxicloroquina/uso terapêutico; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Coronavirus / Tratamento Farmacológico da COVID-19 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Antimicrob Agents Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google